CRYGS

crystallin gamma S

Summary

Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Gamma-crystallins are a homogeneous group of highly symmetrical, monomeric proteins typically lacking connecting peptides and terminal extensions. They are differentially regulated after early development. This gene encodes a protein initially considered to be a beta-crystallin but the encoded protein is monomeric and has greater sequence similarity to other gamma-crystallins. This gene encodes the most significant gamma-crystallin in adult eye lens tissue. Whether due to aging or mutations in specific genes, gamma-crystallins have been involved in cataract formation. [provided by RefSeq, Jul 2008]

Known Variants47 total

rsidPosition (GRCh37)AllelesClassClinVar
rs7477873003:186,256,501C/Tuncertain significance
rs7695077003:186,256,502G/Auncertain significance
rs13891613653:186,256,520G/Auncertain significance
rs24745009843:186,256,572G/Tuncertain significance
rs9151169533:186,256,586G/Auncertain significance
rs9678760423:186,256,601C/Auncertain significance
rs7807134003:186,256,636G/Auncertain significance
rs5709667533:186,256,648C/Tuncertain significance
rs2016422913:186,256,667T/Guncertain significance
rs17139895033:186,256,670T/Cuncertain significance
rs3766532753:186,256,686G/Alikely benign
rs1141862693:186,256,716C/Tlikely benign
rs1441246713:186,256,717C/Tlikely benign
rs3756325983:186,256,723T/Guncertain significance
rs1404218413:186,256,728G/Tbenign
rs12752393793:186,256,753C/Guncertain significance
rs3676801733:186,256,769C/Tlikely benign
rs738879433:186,256,880C/Tbenign
rs1504419053:186,256,961C/Tlikely benign
rs1162127983:186,257,040C/Tlikely benign
rs15538469263:186,257,155C/Tuncertain significance
rs17140024343:186,257,160C/Tuncertain significance
rs17140025053:186,257,161A/Guncertain significance
rs7649691893:186,257,172C/Tuncertain significance
rs7616281473:186,257,184C/Tuncertain significance
rs1448125373:186,257,193C/Tconflicting classifications of pathogenicity
rs7502368063:186,257,194G/Auncertain significance
rs7582374943:186,257,205G/Auncertain significance
rs24745019963:186,257,209A/Tlikely pathogenic
rs24745020713:186,257,269A/Guncertain significance
rs15789566893:186,257,284C/Tpathogenic
rs11843982433:186,257,292G/Clikely pathogenic
rs7647937753:186,257,301C/Tuncertain significance
rs1435078273:186,257,331T/Cconflicting classifications of pathogenicity
rs10356141133:186,257,346T/Cuncertain significance
rs617437143:186,257,353G/Auncertain significance
rs1048937363:186,257,355C/Amissense variantpathogenic
rs1479710153:186,257,369G/Tconflicting classifications of pathogenicity
rs1434240003:186,257,376T/Cuncertain significance
rs1130318383:186,257,384A/Tbenign
rs21087436413:186,257,385A/Tlikely pathogenic
rs730553903:186,257,683G/Cbenign
rs1489396613:186,261,443G/Adownstream gene variant
rs730553983:186,262,041G/Tbenign
rs168608833:186,262,063C/Tlikely benign
rs12614879213:186,262,089A/Guncertain significance
rs786893523:186,262,497G/Abenign

Gene information from NCBI Gene. Variant classifications from ClinVar.